Search

Author/Creator Giorgino, F.

1. A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus. Issue 7 (3rd July 2017)

Authors:
Avogaro, A.; Giaccari, A.; Fioretto, P.; Genovese, S.; Purrello, F.; Giorgino, F.; Del Prato, S.
Journal:
Expert review of clinical pharmacology
Issue:
Volume 10:Issue 7(2017)
Page Start:
763
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome. (4th May 2014)

Authors:
Garruti, G.; de Palo, R.; Rotelli, M. T.; Nocera, S.; Totaro, I.; Nardelli, C.; Panzarino, M. A.; Vacca, M.; Selvaggi, L. E.; Giorgino, F.
Other Names:
Virant-Klun Irma Academic Editor.
Journal:
BioMed research international
Issue:
Volume 2014(2014)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials. Issue 2 (26th November 2019)

Authors:
Davidson, J. A.; Desouza, C.; Fonseca, V.; Frias, J. P.; Van Gaal, L.; Giorgino, F.; Chao, J.; Dex, T. A.; Roberts, M.; Saremi, A.; Leiter, L. A.
Journal:
Diabetic medicine
Issue:
Volume 37:Issue 2(2020)
Page Start:
256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗